Analyst
Access Capital Limited
Equibles does not estimate personal net worth.
Kunal Randhiriya is recorded as Analyst at Access Capital Limited. Kunal Randhiriya has spoken on 2 earnings calls across 2 companies, most recently for Lupin Limited on November 4, 2026. Those appearances were for Lupin Limited and Mankind Pharma Limited. The companies whose calls Kunal Randhiriya spoke on are classified in the Healthcare sector.
“I believe your litigation is still on with the innovator while one of the Indian filers has already settled. So my question is, is this an FY29 opportunity for you?”
“Sheetal ji, you mentioned a few brands like Telmakine, Diderbon doing extremely well. So good to hear that. But some of your other bigger brands like Moxikine, Amlokine, Goodself are not really showing growth.”
Access Capital Limited
Analyst
Transcript header (unverified)
Lupin Limited
Drug Manufacturers - Specialty & Generic · Healthcare
Mankind Pharma Limited
Drug Manufacturers - Specialty & Generic · Healthcare
Earnings Call
Lupin Limited
Earnings Call
Mankind Pharma Limited
